Acinar Cell Carcinoma Of Pancreas

(1-methyl-2-nitro-1H-imidazole-5-yl)methyl N,N'-bis(2-bromoethyl) diamidophosphate, 26 base single stranded phosphodiester DNA oligonucleotide, 3-bromopyruvate, 4-amino-1-[(1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-(hydroxymethyl) cyclopent-2-en-1-yl] pyrimidin-2-one, 4-imino-1, 3-diazobicyclo-[3.1.0]-hexan-2-one, 5'-O-(trans-9''-octadecenoyl)-1-beta-D-2'deoxy-2',2'-difluorocytidine, 5,10-methylene-tetrahydrofolic acid, 5-10-Methylene-tetrahydrofolate, Adenoviral vector of serotype 5 modified to contain a chimeric sequence consisting of a minimal urokinase-type plasminogen activator receptor promoter preceded by three Notch-responsive elements, and coated with oligopeptide end-modified poly (beta-amino) esters, Algenpantucel-L, Antroquinonol, Autologous human adipose perivascular stromal cells genetically modified to secrete soluble tumour necrosis factor-related apoptosis-inducing ligand, Axitinib ( INLYTA ), Bevacizumab ( Equidacent, AVASTIN, Aybintio, MVASI ), Bovine bile extract, Brivudine, Chimeric antibody to mesothelin, Chimeric monoclonal antibody against claudin-18 splice variant 2, Cisplatin (liposomal), Cysteamine bitartrate ( CYSTAGON ), Cytochrome P450 isoform 2B1 gene transfected human embryonic kidney 293 cells encapsulated in polymeric cellulose sulphate, Demcizumab, Deuterium oxide, Devimistat, Eryaspase ( GRASPA ), G17(9) gastrin-diphtheria toxoid conjugate, GVAX, Genetically modified human adenovirus encoding human PH20 hyaluronidase, Glufosfamide, Heat killed whole cell mycobacterium obuense, Heparan sulfate mimetic, Herpes simplex type 1 virus containing cellular B-myb gene as tumour-specific promoter, Human telomerase reverse transcriptase peptide (611-626), Human trtravalent, bi-specific monoclonal antibody that binds and co-inhibits two growth factor receptors; insulin-like growth factor receptor 1 (IGF-1R) and v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 (ErbB3), Humanised IgG4 monoclonal antibody to the human toll-like receptor type 2, Humanized IgG monoclonal antibody hRS7 conjugated to topoisomerase I inhibitor, Immunoglobulin G1, anti-(human tumour-associated calcium signal transducer 2)(human-Mus musculus monoclonal hRS7 heavy chain), disulfide with human-Mus musculus monoclonal hRS7 ê-chain, dimer, hexakis(thioether) with (4S)-4-[[[[4-[[(2S)-2-(4-aminobutyl)-2-[[2-[2-[[26-[4-[[[[4-[(3-mercapto-2,5-dioxo-1-pyrrolidinyl)methyl]cyclohexyl][...][3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, Iodine (131I) anti-CEA sheep-human chimeric monoclonal antibody, Live attenuated Listeria monocytogenes delta actA/delta inlB strain expressing human mesothelin, Masitinib mesilate, Mixture of seven synthetic fragments consisting of p21 RAS peptides, Modified adenovirus serotype 5/35 containing a CMV promoter-driven transgene cassette with the human transgenes for a membrane-bound CD40 ligand and full length 4-1BBL, N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl)amino]isonicotinamide hydrochloride, N1,N14,-diethyl-3,12,-dihydroxyhomospermine, Nanoliposomal irinotecan ( ONIVYDE ), Nimotuzumab ( THERALOC ), PEGylated recombinant human hyaluronidase PH20, Paclitaxel (liposomal), Paclitaxel protein-bound particles ( ABRAXANE ), Pegylated recombinant human interleukin-10, Polyinosine-polycytidylic acid coupled with the polycationic polyethyleneimine, Re188 P2045 somatostatin analog, Recombinant human monoclonal antibody of the IgG1 kappa class against prostate stem cell antigen, Relacorilant, Rubitecan, S-[2,3-bispalmitoyloxy-(2R)-propyl]-cysteinyl-GNNDESNISFKEK, Salirasib, Targeted Gastrin 17 Complexed Peptide, Trabedersen, Yttrium (90Y)-DOTA-radiolabelled humanized monoclonal antibody against mucin 1, [5-amino-1-(4-fluoro-phenyl)-1H-pyrazol-4-yl]-[3-(2,3-dihydroxy-propoxy)-phenyl]-methanone, human reovirus type 3 Dearing strain, motixafortide, sodium 2-hydroxylinoleate